CY1126109T1 - Αναστολεις toy trpc6 - Google Patents
Αναστολεις toy trpc6Info
- Publication number
- CY1126109T1 CY1126109T1 CY20231100270T CY231100270T CY1126109T1 CY 1126109 T1 CY1126109 T1 CY 1126109T1 CY 20231100270 T CY20231100270 T CY 20231100270T CY 231100270 T CY231100270 T CY 231100270T CY 1126109 T1 CY1126109 T1 CY 1126109T1
- Authority
- CY
- Cyprus
- Prior art keywords
- compounds
- processes
- relates
- trpc6
- inhibitors
- Prior art date
Links
- 102000003623 TRPC6 Human genes 0.000 title 1
- 108050001421 Transient receptor potential channel, canonical 6 Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- 238000000034 method Methods 0.000 abstract 3
- 208000037765 diseases and disorders Diseases 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
- C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Cardiology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Η εφεύρεση αφορά σε ενώσεις του τύπου (Ι), και φαρμακευτικώς αποδεκτά άλατα αυτών, όπου R1 έως R7, Α, Υ και L είναι όπως ορίζεται στο παρόν. Η εφεύρεση επίσης αφορά σε φαρμακευτικές συνθέσεις που περιλαμβάνουν αυτές τις ενώσεις, μεθόδους χρήσης αυτών των ενώσεων στη θεραπεία διαφόρων ασθενειών και διαταραχών, διεργασίες για παρασκευή αυτών των ενώσεων και ενδιαμέσων χρήσιμων σε αυτές τις διεργασίες.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762577883P | 2017-10-27 | 2017-10-27 | |
US201862628313P | 2018-02-09 | 2018-02-09 | |
PCT/EP2018/079276 WO2019081637A1 (en) | 2017-10-27 | 2018-10-25 | CARBONYL PYRIDINE DERIVATIVES AND THEIR THERAPEUTIC USES AS TRPC6 INHIBITORS |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1126109T1 true CY1126109T1 (el) | 2023-11-15 |
Family
ID=64270818
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20231100270T CY1126109T1 (el) | 2017-10-27 | 2023-06-07 | Αναστολεις toy trpc6 |
Country Status (30)
Country | Link |
---|---|
US (4) | US10800757B2 (el) |
EP (2) | EP3786160B1 (el) |
JP (2) | JP7217273B6 (el) |
KR (2) | KR20200095467A (el) |
CN (1) | CN111527078B (el) |
AU (2) | AU2018355743B2 (el) |
BR (1) | BR112020007818A2 (el) |
CA (1) | CA3078769A1 (el) |
CL (2) | CL2020001097A1 (el) |
CY (1) | CY1126109T1 (el) |
DK (2) | DK3700902T3 (el) |
ES (2) | ES2924933T3 (el) |
FI (1) | FI3700902T3 (el) |
HR (2) | HRP20220991T1 (el) |
HU (2) | HUE062460T2 (el) |
IL (2) | IL274039B (el) |
LT (2) | LT3700902T (el) |
MX (1) | MX2020004283A (el) |
PE (1) | PE20210154A1 (el) |
PH (1) | PH12020550503A1 (el) |
PL (2) | PL3700902T3 (el) |
PT (2) | PT3786160T (el) |
RS (2) | RS63535B1 (el) |
SA (1) | SA520411843B1 (el) |
SG (2) | SG10202011632RA (el) |
SI (2) | SI3700902T1 (el) |
TW (2) | TWI780246B (el) |
UA (1) | UA128474C2 (el) |
WO (1) | WO2019081637A1 (el) |
ZA (1) | ZA202002372B (el) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL3700902T3 (pl) * | 2017-10-27 | 2023-09-04 | Boehringer Ingelheim International Gmbh | Inhibitory trpc6 |
US11485740B2 (en) * | 2018-02-15 | 2022-11-01 | Boehringer Ingelheim International Gmbh | Inhibitors of TRPC6 |
JP7301861B2 (ja) * | 2018-02-16 | 2023-07-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Trpc6の阻害剤 |
IL315313A (en) * | 2018-08-24 | 2024-10-01 | Xeniopro GmbH | Aromatic molecules for use in the treatment of pathological conditions |
EP3959206A1 (en) * | 2019-04-12 | 2022-03-02 | Boehringer Ingelheim International GmbH | Inhibitors of trpc6 |
JP2021070688A (ja) * | 2019-10-24 | 2021-05-06 | 国立大学法人大阪大学 | 難聴の予防および/または治療用医薬組成物 |
US20230137816A1 (en) | 2020-02-11 | 2023-05-04 | Deutsches Herzzentrum Muenchen Des Freistaates Bayern | Administration of calcium channel trpc6 inhibitors using balloons, stents or other medical devices |
KR20230004650A (ko) * | 2020-04-16 | 2023-01-06 | 베링거 인겔하임 인터내셔날 게엠베하 | 호흡기 병태를 치료하기 위한 trpc6의 억제제 |
AR121846A1 (es) * | 2020-04-16 | 2022-07-13 | Teijin Pharma Ltd | Derivado de arilo o heteroarilo |
CN113105318B (zh) * | 2021-02-23 | 2022-05-20 | 中山大学 | 一种2,2-二氟环丁烷-1-羧酸的制备方法及应用 |
IL310983A (en) | 2021-10-15 | 2024-04-01 | Boehringer Ingelheim Int | TRPC6 inhibitory compounds for the treatment of sepsis |
WO2023106421A1 (ja) * | 2021-12-06 | 2023-06-15 | 国立大学法人熊本大学 | Trpc6の発現を抑制する方法 |
Family Cites Families (50)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991009594A1 (en) | 1989-12-28 | 1991-07-11 | Virginia Commonwealth University | Sigma receptor ligands and the use thereof |
PT100639A (pt) | 1991-06-27 | 1993-09-30 | Univ Virginia Commonwealth | Metodo para o tratamento terapeutico com compostos que sao ligandos ao receptor sigma e compostos ai utilizados, nomeadamente derivados fenilalquil-amina, aminotetralina,piperazina e piperidina |
JP3100984B2 (ja) | 1992-12-02 | 2000-10-23 | ファイザー・インク. | 選択的pde▲下i▼▲下v▼阻害物質としてのカテコールジエーテル類 |
AU754529B2 (en) | 1998-09-22 | 2002-11-21 | Yamanouchi Pharmaceutical Co., Ltd. | Cyanophenyl derivatives |
EP1259485B1 (en) | 2000-02-29 | 2005-11-30 | Millennium Pharmaceuticals, Inc. | BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
MXPA03000458A (es) | 2000-07-20 | 2004-06-02 | Neurogen Corp | Ligandos receptores de capsaicina. |
JP4186518B2 (ja) * | 2001-06-15 | 2008-11-26 | アステラス製薬株式会社 | フェニルピリジン誘導体 |
ATE417038T1 (de) | 2001-06-15 | 2008-12-15 | Astellas Pharma Inc | Phenylpyridincarbonyl piperazinderivate |
NI200300045A (es) | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
DE10222291A1 (de) | 2002-05-18 | 2003-11-27 | Schlafhorst & Co W | Faserbandzuführeinrichtung |
CN1150176C (zh) | 2002-05-22 | 2004-05-19 | 上海医药工业研究院 | 芳烷酮哌嗪衍生物及其应用 |
CA2581745A1 (en) | 2004-10-13 | 2006-04-27 | Neurogen Corporation | Aryl substituted 8-azabicyclo[3.2.1]octane compounds as ligands of the melanin concentrating hormone receptor |
DE102005044814A1 (de) | 2005-05-19 | 2006-11-23 | Grünenthal GmbH | Substituierte Sprio-Verbindungen und deren Verwendung zur Herstellung von Arzneimitteln |
AR056582A1 (es) | 2005-10-28 | 2007-10-10 | Lilly Co Eli | COMPUESTOS DE PIRAZOLIL UREA CON ACTIVIDAD INHIBITORIA DE CINASA P38 Y FORMULACIoN FARMACÉUTICA QUE LO COMPRENDE |
CA2634250A1 (en) | 2005-12-21 | 2007-07-05 | Schering Corporation | Phenoxypiperidines and analogs thereof useful as histamine h3 antagonists |
JP5019768B2 (ja) | 2006-03-23 | 2012-09-05 | 独立行政法人科学技術振興機構 | 新規低分子化合物およびその製造方法 |
PE20090188A1 (es) | 2007-03-15 | 2009-03-20 | Novartis Ag | Compuestos heterociclicos como moduladores de la senda de hedgehog |
JP5082538B2 (ja) | 2007-03-28 | 2012-11-28 | Dic株式会社 | ピペラジン化合物 |
CA2746943A1 (en) | 2008-12-18 | 2010-07-15 | Boehringer Ingelheim International Gmbh | Serotonin 5-ht2b receptor inhibitors |
US20100234603A1 (en) | 2009-03-13 | 2010-09-16 | Xin Linghu | Process for Making Substituted Aryl Sulfone Intermediates |
US20110039850A1 (en) | 2009-08-12 | 2011-02-17 | Mhairi Copland | Leukemia Treatment |
CN102686579A (zh) | 2009-10-09 | 2012-09-19 | Irm责任有限公司 | 作为gpr119活性调节剂的化合物和组合物 |
CN102665700A (zh) | 2009-11-18 | 2012-09-12 | 诺瓦提斯公司 | 治疗实体瘤和其它恶性肿瘤的方法和组合物 |
CN102883607B (zh) | 2010-03-01 | 2015-07-22 | Gtx公司 | 用于治疗癌的化合物 |
ES2653966T3 (es) | 2010-04-27 | 2018-02-09 | Mitsubishi Tanabe Pharma Corporation | Nuevo derivado de amida y su uso como medicina |
CN103221404B (zh) | 2010-05-13 | 2015-12-16 | 安姆根有限公司 | 可用作pde10抑制剂的不饱和氮杂环化合物 |
KR101764952B1 (ko) | 2010-07-29 | 2017-08-03 | 리겔 파마슈티칼스, 인크. | Ampk-활성화 헤테로시클릭 화합물 및 그의 사용 방법 |
US9586928B2 (en) | 2011-05-16 | 2017-03-07 | The Scripps Research Institute | Modulators of the nuclear hormone receptor ROR |
JP5800786B2 (ja) | 2011-10-26 | 2015-10-28 | 田辺三菱製薬株式会社 | 新規アミド誘導体を有効成分として含有する医薬組成物 |
US9139585B2 (en) | 2011-10-31 | 2015-09-22 | Merck Sharp & Dohme Corp. | Inhibitors of the Renal Outer Medullary Potassium channel |
CN103360343B (zh) | 2012-03-30 | 2017-04-19 | 凯惠药业(上海)有限公司 | 一种哌嗪酰胺类化合物的制备方法 |
WO2014139144A1 (en) | 2013-03-15 | 2014-09-18 | Agios Pharmaceuticals, Inc. | Therapeutic compounds and compositions |
MX366678B (es) * | 2013-05-27 | 2019-07-19 | Hoffmann La Roche | Nuevos compuestos de 3,4-dihidro-2h-isoquinolin-1-ona y 2,3-dihidro-isoindol-1-ona. |
US20150087673A1 (en) | 2013-09-26 | 2015-03-26 | Rigel Pharmaceuticals, Inc. | Methods for using and biomarkers for ampk-activating compounds |
US20160297761A1 (en) | 2014-01-06 | 2016-10-13 | Rhizen Pharmaceuticals Sa | Novel inhibitors of glutaminase |
WO2015199206A1 (ja) | 2014-06-27 | 2015-12-30 | 塩野義製薬株式会社 | Trpv4阻害活性を有する6員環誘導体 |
UY36391A (es) | 2014-11-05 | 2016-06-01 | Flexus Biosciences Inc | Compuestos moduladores de la enzima indolamina 2,3-dioxigenasa (ido1), sus métodos de síntesis y composiciones farmacèuticas que las contienen |
MA41598A (fr) | 2015-02-25 | 2018-01-02 | Constellation Pharmaceuticals Inc | Composés thérapeutiques de pyridazine et leurs utilisations |
US20180305334A1 (en) | 2015-10-14 | 2018-10-25 | Aquinnah Pharmaceuticals, Inc. | Compounds, compositions and methods of use against stress granules |
CN107176927B (zh) | 2016-03-12 | 2020-02-18 | 福建金乐医药科技有限公司 | 组蛋白去甲基化酶lsd1抑制剂 |
MX2018011105A (es) | 2016-03-16 | 2018-11-22 | Kura Oncology Inc | Inhibidores sustituidos de menina-mll y metodos de uso. |
WO2017222930A1 (en) | 2016-06-20 | 2017-12-28 | Rutgers, The State University Of New Jersey | Therapeutic compounds |
CN107540636A (zh) | 2016-06-29 | 2018-01-05 | 成都贝斯凯瑞生物科技有限公司 | 一种含氮杂环衍生物及其应用 |
CN106317050B (zh) * | 2016-08-24 | 2018-11-23 | 烟台大学 | 一种苯基噻唑衍生物及其制备方法与应用 |
WO2018159827A1 (ja) | 2017-03-03 | 2018-09-07 | 国立大学法人京都大学 | 植物ステロイドホルモン(ブラシノライド)様活性をもつ非ステロイド化合物の創製 |
WO2018170225A1 (en) | 2017-03-15 | 2018-09-20 | Athenex, Inc. | Biaryl piperidine amide compounds and methods of use thereof |
PL3700902T3 (pl) | 2017-10-27 | 2023-09-04 | Boehringer Ingelheim International Gmbh | Inhibitory trpc6 |
CA3080949C (en) * | 2017-11-16 | 2024-04-16 | Principia Biopharma Inc. | Immunoproteasome inhibitors |
US11485740B2 (en) | 2018-02-15 | 2022-11-01 | Boehringer Ingelheim International Gmbh | Inhibitors of TRPC6 |
JP7301861B2 (ja) | 2018-02-16 | 2023-07-03 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Trpc6の阻害剤 |
-
2018
- 2018-10-25 PL PL18800513.6T patent/PL3700902T3/pl unknown
- 2018-10-25 PE PE2020000424A patent/PE20210154A1/es unknown
- 2018-10-25 EP EP20197194.2A patent/EP3786160B1/en active Active
- 2018-10-25 SI SI201830924T patent/SI3700902T1/sl unknown
- 2018-10-25 HU HUE18800513A patent/HUE062460T2/hu unknown
- 2018-10-25 CN CN201880070122.4A patent/CN111527078B/zh active Active
- 2018-10-25 PL PL20197194.2T patent/PL3786160T3/pl unknown
- 2018-10-25 PT PT201971942T patent/PT3786160T/pt unknown
- 2018-10-25 WO PCT/EP2018/079276 patent/WO2019081637A1/en active Application Filing
- 2018-10-25 US US16/170,154 patent/US10800757B2/en not_active Ceased
- 2018-10-25 RS RS20220752A patent/RS63535B1/sr unknown
- 2018-10-25 ES ES20197194T patent/ES2924933T3/es active Active
- 2018-10-25 HU HUE20197194A patent/HUE059450T2/hu unknown
- 2018-10-25 ES ES18800513T patent/ES2946274T3/es active Active
- 2018-10-25 MX MX2020004283A patent/MX2020004283A/es unknown
- 2018-10-25 JP JP2020523445A patent/JP7217273B6/ja active Active
- 2018-10-25 US US16/170,178 patent/US10889568B2/en active Active
- 2018-10-25 SG SG10202011632RA patent/SG10202011632RA/en unknown
- 2018-10-25 BR BR112020007818-2A patent/BR112020007818A2/pt unknown
- 2018-10-25 EP EP18800513.6A patent/EP3700902B8/en active Active
- 2018-10-25 FI FIEP18800513.6T patent/FI3700902T3/fi active
- 2018-10-25 LT LTEPPCT/EP2018/079276T patent/LT3700902T/lt unknown
- 2018-10-25 TW TW107137733A patent/TWI780246B/zh active
- 2018-10-25 AU AU2018355743A patent/AU2018355743B2/en active Active
- 2018-10-25 RS RS20230382A patent/RS64271B1/sr unknown
- 2018-10-25 HR HRP20220991TT patent/HRP20220991T1/hr unknown
- 2018-10-25 LT LTEP20197194.2T patent/LT3786160T/lt unknown
- 2018-10-25 CA CA3078769A patent/CA3078769A1/en active Pending
- 2018-10-25 SI SI201830732T patent/SI3786160T1/sl unknown
- 2018-10-25 DK DK18800513.6T patent/DK3700902T3/da active
- 2018-10-25 SG SG11202003367TA patent/SG11202003367TA/en unknown
- 2018-10-25 UA UAA202003145A patent/UA128474C2/uk unknown
- 2018-10-25 PT PT188005136T patent/PT3700902T/pt unknown
- 2018-10-25 TW TW109138850A patent/TWI780511B/zh active
- 2018-10-25 KR KR1020207014013A patent/KR20200095467A/ko active IP Right Grant
- 2018-10-25 DK DK20197194.2T patent/DK3786160T3/da active
- 2018-10-25 HR HRP20230502TT patent/HRP20230502T1/hr unknown
- 2018-10-25 KR KR1020207031025A patent/KR20200125758A/ko not_active Application Discontinuation
-
2020
- 2020-04-19 IL IL274039A patent/IL274039B/en unknown
- 2020-04-23 CL CL2020001097A patent/CL2020001097A1/es unknown
- 2020-04-26 SA SA520411843A patent/SA520411843B1/ar unknown
- 2020-04-27 PH PH12020550503A patent/PH12020550503A1/en unknown
- 2020-05-04 ZA ZA2020/02372A patent/ZA202002372B/en unknown
- 2020-09-22 IL IL277493A patent/IL277493B/en unknown
- 2020-10-02 CL CL2020002562A patent/CL2020002562A1/es unknown
- 2020-10-06 AU AU2020250185A patent/AU2020250185B2/en active Active
- 2020-10-08 JP JP2020170563A patent/JP6979502B2/ja active Active
- 2020-12-08 US US17/115,667 patent/US20210163449A1/en not_active Abandoned
-
2021
- 2021-05-28 US US17/334,097 patent/USRE49699E1/en active Active
-
2023
- 2023-06-07 CY CY20231100270T patent/CY1126109T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1126109T1 (el) | Αναστολεις toy trpc6 | |
CY1121413T1 (el) | Διυδροπυρρολοπυριδινης αναστολεις ror-γαμμα | |
CY1124239T1 (el) | Ενωσεις αμινο-τριαζολοπυριδινης και χρηση αυτων στην αγωγη του καρκινου | |
CY1121858T1 (el) | Παραγωγα αρυλμεθοξυ ισοϊνδολινης και συνθεσεις που περιλαμβανουν αυτες και μεθοδοι χρησης αυτων | |
CY1122918T1 (el) | Προφαρμακα ενωσης αναστολεα jak για την θεραπεια μιας γαστρεντερικης φλεγμονωδους νοσου | |
CY1122610T1 (el) | Αλκοξυ πυραζολια ως ενεργοποιητες διαλυτης γουανυλικης κυκλασης | |
CY1123395T1 (el) | Ενωσεις καρβοξαμιδιων ινδολης χρησιμες ως αναστολεις κινασων | |
CY1124404T1 (el) | Παραγωγα χολικου οξεος ως αγωνιστες fxr/tgr5 και μεθοδοι χρησης αυτων | |
CY1119056T1 (el) | Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna | |
CY1123059T1 (el) | Αναστολη του διαυλου ιοντων παροδικου δυναμικου του υποδοχεα α1 | |
CY1119939T1 (el) | Παραγωγα 2,3-διϋδρο-βενζο[1,4]οξαζιν και σχετικες ενωσεις οπως αναστολεις φωσφοϊνοσιτινης-3 κινασης (ρι3κ) για τη θεραπεια παραδειγματος χαρην της ρευματοειδους αρθριτιδας | |
CY1123627T1 (el) | Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
EA201790078A1 (ru) | Ингибиторы mnk и связанные с ними способы | |
CY1124243T1 (el) | Αναστολη του ιοντικου διαυλου υποδοχεα παροδικου δυναμικου α1 | |
CY1117584T1 (el) | Παραγωγα 1-βενζυλ-3-υδροξυμεθυλινδαζολης και η χρηση τους στη θεραπευτικη αντιμετωπιση νοσων που βασιζονται στην εκφραση των mcp-1, cx3cr1 | |
CO2019009722A2 (es) | Dendrímeros terapéuticos | |
EA201790246A1 (ru) | Гетероциклические карбоновые кислоты в качестве активаторов растворимой гуанилатциклазы | |
CY1121063T1 (el) | Αναστολεις της συνθασης της αλδοστερονης | |
CY1126082T1 (el) | Τροποποιητες toy trex1 | |
CY1123494T1 (el) | Enωσeiς etepoapyλo-kapboξamiδioy ως anaσtoλeiς thς ripk2 | |
CY1121650T1 (el) | Αναστολεις συνθασης αλδοστερονης | |
CY1120836T1 (el) | Ενωσεις 1,3,4-θειαδιαζοαης και η χρηση τους στη θεραπευτικη αντιμετωπιση του καρκινου | |
DOP2017000034A (es) | Compuestos de imidazopiridazina | |
CU20160140A7 (es) | CROMENE Y 1,1 A,2,7B- tetrahidrociclopropa[C]CROMENE PIRIDOPIRAZINEDIONES COMO MODULADORES DE GAMMA-SECRETASA |